Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Hi-Tech Pharmacal Co. Company Profile (NASDAQ:HITK)

Consensus Ratings for Hi-Tech Pharmacal Co. (NASDAQ:HITK) (?)
Ratings Breakdown: 2 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $44.20 (1.63% upside)

Analysts' Ratings History for Hi-Tech Pharmacal Co. (NASDAQ:HITK)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/12/2013ZacksUpgradeUnderperform -> Neutral$44.20ViewTweet This Rating  Share This Rating on StockTwits
10/9/2013ZacksDowngradeNeutral -> Underperform$41.10ViewTweet This Rating  Share This Rating on StockTwits
9/10/2013ZacksUpgradeUnderperform -> Neutral$44.10ViewTweet This Rating  Share This Rating on StockTwits
8/27/2013Standpoint ResearchDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
7/12/2013ZacksDowngradeNeutral -> Underperform$32.40ViewTweet This Rating  Share This Rating on StockTwits
7/10/2013Needham & Company LLCReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
3/14/2013Standpoint ResearchUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
3/8/2013Canaccord GenuityLower Price TargetBuy$42.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
12/7/2012Canaccord GenuityReiterated RatingBuy -> BuyViewTweet This Rating  Share This Rating on StockTwits
11/30/2012Standpoint ResearchDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
8/15/2012Canaccord GenuityReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
7/25/2012CRT CapitalUpgradeFair Value -> BuyViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/22/2012 forward)